FI921058A0 - Anvaendning av thioredoxin vid behandling av elakartade transformade celler i djur och maenniska. - Google Patents

Anvaendning av thioredoxin vid behandling av elakartade transformade celler i djur och maenniska.

Info

Publication number
FI921058A0
FI921058A0 FI921058A FI921058A FI921058A0 FI 921058 A0 FI921058 A0 FI 921058A0 FI 921058 A FI921058 A FI 921058A FI 921058 A FI921058 A FI 921058A FI 921058 A0 FI921058 A0 FI 921058A0
Authority
FI
Finland
Prior art keywords
transformade
maenniska
elakartade
djur
celler
Prior art date
Application number
FI921058A
Other languages
English (en)
Finnish (fi)
Inventor
Anders Rosen
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI921058A0 publication Critical patent/FI921058A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y108/00—Oxidoreductases acting on sulfur groups as donors (1.8)
    • C12Y108/01—Oxidoreductases acting on sulfur groups as donors (1.8) with NAD+ or NADP+ as acceptor (1.8.1)
    • C12Y108/01008—Protein-disulfide reductase (1.8.1.8), i.e. thioredoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
FI921058A 1989-09-12 1992-03-11 Anvaendning av thioredoxin vid behandling av elakartade transformade celler i djur och maenniska. FI921058A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8903003A SE8903003D0 (sv) 1989-09-12 1989-09-12 Novel medical use
PCT/SE1990/000578 WO1991004320A1 (en) 1989-09-12 1990-09-10 The use of thioredoxin in the treatment of malignantly transformed cells in animals and man

Publications (1)

Publication Number Publication Date
FI921058A0 true FI921058A0 (fi) 1992-03-11

Family

ID=20376862

Family Applications (1)

Application Number Title Priority Date Filing Date
FI921058A FI921058A0 (fi) 1989-09-12 1992-03-11 Anvaendning av thioredoxin vid behandling av elakartade transformade celler i djur och maenniska.

Country Status (12)

Country Link
EP (1) EP0489113A1 (xx)
JP (1) JPH05500216A (xx)
AU (1) AU641942B2 (xx)
CA (1) CA2065454A1 (xx)
DD (1) DD298056A5 (xx)
FI (1) FI921058A0 (xx)
GR (1) GR1001151B (xx)
HU (1) HUT62932A (xx)
IE (1) IE903233A1 (xx)
PT (1) PT95284A (xx)
SE (1) SE8903003D0 (xx)
WO (1) WO1991004320A1 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE196606T1 (de) 1992-11-13 2000-10-15 Idec Pharma Corp Therapeutische verwendung von chimerischen und markierten antikörpern, die gegen ein differenzierung-antigen gerichtet sind, dessen expression auf menschliche b lymphozyt beschränkt ist, für die behandlung von b-zell-lymphoma
US7744877B2 (en) 1992-11-13 2010-06-29 Biogen Idec Inc. Expression and use of anti-CD20 Antibodies
WO1998000160A1 (en) * 1996-06-28 1998-01-08 Nat Jewish Ct Immun & Respirat USE OF THIOREDOXIN-LIKE MOLECULES FOR INDUCTION OF MnSOD TO TREAT OXIDATIVE DAMAGE
US6689775B2 (en) 1999-06-03 2004-02-10 Arizona Board Of Regents, Acting On Behalf Of The University Of Arizona Uses of thioredoxin
EP0946192A1 (en) * 1996-12-06 1999-10-06 Garth Powis Uses of thioredoxin
US5919657A (en) * 1997-04-09 1999-07-06 Incyte Pharmaceuticals, Inc. Nucleic acids encoding human thioredoxin protein; related reagents
US7585645B2 (en) 1997-05-27 2009-09-08 Sembiosys Genetics Inc. Thioredoxin and thioredoxin reductase containing oil body based products
US6566514B1 (en) 1998-01-30 2003-05-20 Genesense Technologies Inc. Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth
DE69939939D1 (de) 1998-08-11 2009-01-02 Idec Pharma Corp Kombinationstherapien gegen b-zell-lymphome beinhaltend die verabreichung von anti-cd20-antikörpern
KR20010103655A (ko) 1998-11-09 2001-11-23 케네쓰 제이. 울코트 키메라 항-ｃｄ２０항체를 이용한 순환성 종양세포와관련된 혈액학적 악성종양의 치료법
US8557244B1 (en) 1999-08-11 2013-10-15 Biogen Idec Inc. Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody
WO2002016600A2 (en) * 2000-08-25 2002-02-28 Curagen Corporation Novel proteins and nucleic acids encoding same
WO2004024868A2 (en) 2002-09-10 2004-03-25 National Jewish Medical And Research Center Product and process for liquefaction of mucus or sputum
WO2014145735A2 (en) 2013-03-15 2014-09-18 Orpro Therapeutics, Inc. Product and process for mucus viscosity normalization

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2633295B2 (ja) * 1987-06-12 1997-07-23 味の素株式会社 ヒトａｄｆをコードする遺伝子

Also Published As

Publication number Publication date
JPH05500216A (ja) 1993-01-21
IE903233A1 (en) 1991-03-27
HUT62932A (en) 1993-06-28
CA2065454A1 (en) 1991-03-13
EP0489113A1 (en) 1992-06-10
HU9200821D0 (en) 1992-05-28
SE8903003D0 (sv) 1989-09-12
WO1991004320A1 (en) 1991-04-04
PT95284A (pt) 1991-08-14
GR900100679A (en) 1992-01-20
DD298056A5 (de) 1992-02-06
AU641942B2 (en) 1993-10-07
GR1001151B (el) 1993-05-24
AU6433690A (en) 1991-04-18

Similar Documents

Publication Publication Date Title
FI881956A0 (fi) Foerfarande och anordning vid antenn- och mottagningssystem av en radioteodolit.
FI880772A0 (fi) Foerfarande foer reglering av luftkonditionering och luftkonditioneringsanordning foer anvaendning vid foerfarandet.
FI884187A (fi) Foerfarande och anordning foer lokalisering av elektroder faestade vid kroppen av en maenniska, i synnerhet huvudet.
FI891344A0 (fi) Foerfarande och anordning i torkningspartiet av en belaeggningsmaskin eller motsvarande.
FI921058A0 (fi) Anvaendning av thioredoxin vid behandling av elakartade transformade celler i djur och maenniska.
FI911904A0 (fi) Foerbaettringar i och vid supraledande kompositledare.
FI902100A0 (fi) Foerpackning foer upphettande eller kokande av en matprodukt i en hetluftsugn.
FI882128A (fi) Filtreringsfoerfarande och anordning foer anvaendning vid foerfarandet.
FI902024A0 (fi) Foerfarande foer maongfaldig oxidering av steroider och i foerfarandet anvaendbara gentekniskt modifierade celler.
FI883880A (fi) Foerfarande och anordning vid pollinering.
FI910340A0 (fi) Anordning foer anvaendning av svetselektroder eller svetstaenger i en motstaendsvetsmaskin.
FI912411A0 (fi) Trialkylsilylestrar av aminosyror och deras anvaendning vid syntesen av peptider.
FI884323A0 (fi) Behandlingsbaenk foer anvaendning vid fysikalisk rehabilitering och vaord.
FI883025A (fi) Foerfarande och anordning foer oeverbelastnings- och kortslutningsskydd vid slutstyranordningar.
FI885230A0 (fi) Anordning foer hantering av returburkar och foerfarande vid behandling av returburkar.
FI883127A0 (fi) Luftfoerdelningsfoerfarande och anlaeggning foer anvaendning vid foerfarandet.
FI904160A0 (fi) Vattenloeslig eller i vatten dispergerbar fotopolymeriserbar blandning och anvaendning av denna foer tryckningsaendamaol.
FI882312A0 (fi) Foerfarande och anordning vid pressbehandling av fiberbana.
FI885634A0 (fi) Anordning och foerfarande foer foerstoering av celler i tumoerer.
FI895454A (fi) Foerfarande och kopplingssystem foer kontroll av cellers skick i seriekopplade ackumulatorer vid anvaendning av servicefria slutna ackumulatorer.
FI883126A0 (fi) Foerfarande vid torkning av vattenhaltigt aemne i en kraftverksprocess och torkanordning foer anvaendning vid foerfarandet.
FI883125A0 (fi) Torkningsfoerfarande i kraftverksprocess och torkanordning foer anvaendning vid foerfarandet.
FI882763A (fi) Punktventilationsfoerfarande foer arbetspunkt och anlaeggning foer anvaendning vid foerfarandet.
FI885575A0 (fi) Foerfarande och anordning foer anvaendning vid inlindningsmaskiner.
FI881849A0 (fi) Foerpapprings- och taningsfoerfarande och vid foerfarandet anvaend tana-ark.

Legal Events

Date Code Title Description
FD Application lapsed